Positions Diverge In US Cost-Conscious User-Fee Negotiations
This article was originally published in Clinica
Executive Summary
The priorities of the FDA and device manufacturers are diverging as the focus of the negotiations for the next medical device user program has shifted to limiting costs, minutes from a March 4 negotiation meeting show.